Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) Shares Outstanding (Weighted Average) (2018 - 2025)

Evolus (EOLS) has disclosed Shares Outstanding (Weighted Average) for 8 consecutive years, with $64.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 3.95% year-over-year to $64.5 million, compared with a TTM value of $64.5 million through Dec 2025, up 3.95%, and an annual FY2025 reading of $64.5 million, up 3.95% over the prior year.
  • Shares Outstanding (Weighted Average) was $64.5 million for Q4 2025 at Evolus, roughly flat from $64.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $64.5 million in Q2 2025 and bottomed at $37.1 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $57.3 million, with a median of $56.9 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) soared 63.06% in 2021, then rose 1.34% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $49.8 million in 2021, then rose by 12.64% to $56.1 million in 2022, then grew by 1.52% to $56.9 million in 2023, then rose by 8.96% to $62.0 million in 2024, then increased by 3.95% to $64.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for EOLS at $64.5 million in Q4 2025, $64.3 million in Q3 2025, and $64.5 million in Q2 2025.